Canopy Growth Corp $ 21.94 -0.19 (-0.86%)
Warning! GuruFocus has detected 2 Severe warning signs with CGC. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for CGC (Canopy Growthrp) from 2010 to Feb 18 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Canopy Growth stock (CGC) PE ratio as of Feb 18 2020 is 0. More Details
Canopy Growth PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Canopy Growth PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NYSE:ELAN SZSE:300122 XPAR:IPN XSWX:VIFN SZSE:000538 SHSE:600196 NAS:MYL NSE:SUNPHARMA SHSE:600332 TSE:4523 XTAE:TEVA TSX:BHC SZSE:000661 NYSE:CTLT OCSE:LUN NYSE:PRGO SZSE:000963 TSE:4506 HKSE:03320 SZSE:002001
Address 1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Canopy Growth Corp through its subsidiaries is the licensed producer of medical marijuana in Canada. The company grows, produces and sells medical marijuana. It operates diverse brands and variety supported by over half million square feet of indoor and greenhouse marijuana production. It sells medical marijuana under various brand names including Tweed, Bedrocan, and Mettrum. A majority of the revenue is derived from the sale of medical marijuana by Tweed and Bedrocan in Canada.